These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21532888)

  • 21. Poly (ADP-ribose) polymerases inhibitor, Zj6413, as a potential therapeutic agent against breast cancer.
    Zhou Q; Ji M; Zhou J; Jin J; Xue N; Chen J; Xu B; Chen X
    Biochem Pharmacol; 2016 May; 107():29-40. PubMed ID: 26920250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pro-oncogenic role of alternative p38 mitogen-activated protein kinases p38γ and p38δ, linking inflammation and cancer in colitis-associated colon cancer.
    Del Reino P; Alsina-Beauchamp D; Escós A; Cerezo-Guisado MI; Risco A; Aparicio N; Zur R; Fernandez-Estévez M; Collantes E; Montans J; Cuenda A
    Cancer Res; 2014 Nov; 74(21):6150-60. PubMed ID: 25217523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer.
    Cardnell RJ; Feng Y; Mukherjee S; Diao L; Tong P; Stewart CA; Masrorpour F; Fan Y; Nilsson M; Shen Y; Heymach JV; Wang J; Byers LA
    PLoS One; 2016; 11(4):e0152584. PubMed ID: 27055253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential anti-proliferative activities of poly(ADP-ribose) polymerase (PARP) inhibitors in triple-negative breast cancer cells.
    Chuang HC; Kapuriya N; Kulp SK; Chen CS; Shapiro CL
    Breast Cancer Res Treat; 2012 Jul; 134(2):649-59. PubMed ID: 22678161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis.
    Muñoz-Gámez JA; Martín-Oliva D; Aguilar-Quesada R; Cañuelo A; Nuñez MI; Valenzuela MT; Ruiz de Almodóvar JM; De Murcia G; Oliver FJ
    Biochem J; 2005 Feb; 386(Pt 1):119-25. PubMed ID: 15456408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of proliferation and invasiveness of ovarian cancer C13* cells by a poly(ADP-ribose) polymerase inhibitor and the role of nuclear factor-κB.
    Wang Z; Li Y; Lv S; Tian Y
    J Int Med Res; 2013 Oct; 41(5):1577-85. PubMed ID: 24097829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poly(ADP-ribose)-dependent regulation of Snail1 protein stability.
    Rodríguez MI; González-Flores A; Dantzer F; Collard J; de Herreros AG; Oliver FJ
    Oncogene; 2011 Oct; 30(42):4365-72. PubMed ID: 21577210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of Kif4A in doxorubicin-induced apoptosis in breast cancer cells.
    Wang H; Lu C; Li Q; Xie J; Chen T; Tan Y; Wu C; Jiang J
    Mol Cells; 2014 Nov; 37(11):812-8. PubMed ID: 25377255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A quinazoline-derivative compound with PARP inhibitory effect suppresses hypertension-induced vascular alterations in spontaneously hypertensive rats.
    Magyar K; Deres L; Eros K; Bruszt K; Seress L; Hamar J; Hideg K; Balogh A; Gallyas F; Sumegi B; Toth K; Halmosi R
    Biochim Biophys Acta; 2014 Jul; 1842(7):935-44. PubMed ID: 24657811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PTPH1 dephosphorylates and cooperates with p38gamma MAPK to increase ras oncogenesis through PDZ-mediated interaction.
    Hou SW; Zhi HY; Pohl N; Loesch M; Qi XM; Li RS; Basir Z; Chen G
    Cancer Res; 2010 Apr; 70(7):2901-10. PubMed ID: 20332238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PEST-containing nuclear protein mediates the proliferation, migration, and invasion of human neuroblastoma cells through MAPK and PI3K/AKT/mTOR signaling pathways.
    Wu DD; Gao YR; Li T; Wang DY; Lu D; Liu SY; Hong Y; Ning HB; Liu JP; Shang J; Shi JF; Wei JS; Ji XY
    BMC Cancer; 2018 May; 18(1):499. PubMed ID: 29716528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poly (ADP-ribose) polymerase inhibition enhances trastuzumab antitumour activity in HER2 overexpressing breast cancer.
    García-Parra J; Dalmases A; Morancho B; Arpí O; Menendez S; Sabbaghi M; Zazo S; Chamizo C; Madoz J; Eroles P; Servitja S; Tusquets I; Yelamos J; Lluch A; Arribas J; Rojo F; Rovira A; Albanell J
    Eur J Cancer; 2014 Oct; 50(15):2725-34. PubMed ID: 25128455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer.
    Shi YY; Small GW; Orlowski RZ
    Breast Cancer Res Treat; 2006 Nov; 100(1):33-47. PubMed ID: 16807678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the gene encoding poly(ADP-ribose) polymerase-1 is modulated by fibronectin during corneal wound healing.
    Zaniolo K; Gingras ME; Audette M; Guérin SL
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4199-210. PubMed ID: 17003407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is p38γ MAPK a metastasis-promoting gene or an oncogenic property-maintaining gene?
    Meng F; Wu G
    Cell Cycle; 2013 Jul; 12(14):2329-30. PubMed ID: 24067375
    [No Abstract]   [Full Text] [Related]  

  • 37. p38γ Mitogen-activated protein kinase signals through phosphorylating its phosphatase PTPH1 in regulating ras protein oncogenesis and stress response.
    Hou S; Suresh PS; Qi X; Lepp A; Mirza SP; Chen G
    J Biol Chem; 2012 Aug; 287(33):27895-905. PubMed ID: 22730326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p38γ MAPK is required for inflammation-associated colon tumorigenesis.
    Yin N; Qi X; Tsai S; Lu Y; Basir Z; Oshima K; Thomas JP; Myers CR; Stoner G; Chen G
    Oncogene; 2016 Feb; 35(8):1039-48. PubMed ID: 25961922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1.
    Yoon JH; Ahn SG; Lee BH; Jung SH; Oh SH
    Biochem Pharmacol; 2012 Mar; 83(6):747-57. PubMed ID: 22226932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of poly(ADP-ribose) polymerase 1 protects against acute myeloid leukemia by suppressing the myeloproliferative leukemia virus oncogene.
    Wang L; Cai W; Zhang W; Chen X; Dong W; Tang D; Zhang Y; Ji C; Zhang M
    Oncotarget; 2015 Sep; 6(29):27490-504. PubMed ID: 26314963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.